An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C
Saturday, June 19, 2021 from 2-3 pm PDT
The session will cover the following information:
- Cardiovascular disease and its mortality and morbidity
- Unique mechanism of action for two treatment options
- Efficacy data for two treatment options
- Safety data for two treatment options
- Overview of the ongoing Outcomes trial
Matthew Budoff, MD
Professor of Medicine, UCLA
Endowed Chair of Preventive Cardiology
Lundquist Institute
Torrance, CA
Please see full Prescribing Information for NEXLETOL and NEXLIZET.
Published
June 3, 2021
Created by
